Related Experiment Video
Updated: Jun 4, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial
Marisa Ann Azad1, Heidi Esther Katrina Huttunen-Hennelly, Cynthia Ross Friedman
1Department of Biological Sciences, Faculty of Science, Thompson Rivers University, 900 McGill Road, Kamloops, BC V2C 5N3, Canada.
Abstract:
In light of the era of microbial drug resistance, the current study aimed to better understand the relationships between sequence, higher-order structure, and mechanism of action for five designed peptides against multidrug-resistant (MDR) pathogens. All peptides studied were 15 residues long, were polycationic, adopted alpha-helical structures within hydrophobic environments (excluding the d-amino acid-substituted peptide MA-d), and contained N-terminal glycine residues, a novel antimicrobial peptide (AMP) design principle. Increasing hydrophobicity enhanced MICs (≤500 μg/ml to ≤7.4 μg/ml) without significantly increasing hemolytic activity (18% maximum hemolysis at 3,400 μg/ml). To the best of our knowledge, this is the first study to have successfully adapted and used a transmission electron microscopy (TEM) immunogold method to investigate the mechanism of action of short (∼15 residues long) AMPs within bacteria. We propose a "floodgate" mechanism to possibly explain membrane deformation and the relative absence of membrane-associated peptides 10 h into incubation.
Insights
This study explored antimicrobial peptides (AMPs) against drug-resistant pathogens. Increasing peptide hydrophobicity improved efficacy without significant toxicity, revealing a novel "floodgate" mechanism.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- The rise of microbial drug resistance necessitates novel therapeutic strategies.
- Antimicrobial peptides (AMPs) are a promising class of therapeutics, but their design and mechanisms of action require further elucidation.
- Understanding the structure-activity relationship of AMPs is crucial for developing effective treatments against multidrug-resistant (MDR) pathogens.
Purpose of the Study:
- To investigate the relationship between sequence, higher-order structure, and mechanism of action for five designed antimicrobial peptides (AMPs).
- To evaluate the efficacy of these AMPs against multidrug-resistant (MDR) pathogens.
- To explore a novel AMP design principle involving N-terminal glycine residues.
Main Methods:
- Design and synthesis of five 15-residue polycationic peptides with varying hydrophobicity.
- Assessment of antimicrobial activity using minimum inhibitory concentrations (MICs).
- Evaluation of hemolytic activity.
- Adaptation and application of transmission electron microscopy (TEM) immunogold labeling to visualize AMP-bacterial interactions.
- Structural analysis of peptide secondary structures in hydrophobic environments.
Main Results:
- All designed peptides, except the d-amino acid substituted one, adopted alpha-helical structures in hydrophobic conditions.
- Increasing peptide hydrophobicity significantly enhanced antimicrobial activity (MICs reduced from ≤500 μg/ml to ≤7.4 μg/ml).
- Hemolytic activity remained low, with a maximum of 18% hemolysis at 3,400 μg/ml.
- The study successfully employed TEM immunogold labeling to study the mechanism of action of short AMPs within bacteria.
- A novel 'floodgate' mechanism is proposed to explain observed membrane deformation and peptide localization.
Conclusions:
- Designed AMPs with increased hydrophobicity demonstrate potent activity against MDR pathogens with minimal hemolytic toxicity.
- The N-terminal glycine residue represents a novel design principle for AMPs.
- The developed TEM immunogold method is effective for studying the mechanism of action of short AMPs.
- The proposed 'floodgate' mechanism offers new insights into AMP-bacterial membrane interactions.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Immunogold Electron Microscopy
